Weichang Zhou
Director/Board Member bij WUXI BIOLOGICS (CAYMAN) INC.
Vermogen: 451 558 $ op 31-03-2024
Profiel
Momenteel bekleedt Weichang Zhou de functie van uitvoerend directeur, Chief Technology Officer & EVP bij Wuxi Biologics (Cayman), Inc. Daarvoor bekleedde hij de functie van Associate Director bij Merck & Co, Inc. Dr. Zhou behaalde een doctoraatsdiploma aan de Jiangxi University of Science & Technology en een doctoraat aan de Universiteit van Hannover.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 27-03-2024 | 247 139 ( 0.01% ) | 451 558 $ | 31-03-2024 |
Actieve functies van Weichang Zhou
| Bedrijven | Functie | Begin |
|---|---|---|
| WUXI BIOLOGICS (CAYMAN) INC. | Director/Board Member | 01-05-2016 |
| WUXI XDC CAYMAN INC. | Director/Board Member | 01-12-2020 |
Eerdere bekende functies van Weichang Zhou
| Bedrijven | Functie | Einde |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Director/Board Member | 01-12-2012 |
| PDL BIOPHARMA, INC. | Director/Board Member | 01-02-2008 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01-10-2002 |
Opleiding van Weichang Zhou
| University of Hannover | Doctorate Degree |
| Jiangxi University of Science & Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
| WUXI XDC CAYMAN INC. | Commercial Services |
| Bedrijven in privébezit | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
